<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://dermfield.com/articles/unilever-reaches-new-settlement-in-dry-shampoo-benzene-class-action</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T09:46:32.346Z</news:publication_date>
      <news:title>Unilever Reaches New Settlement in Dry Shampoo Benzene Class Action</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/eu-signs-off-on-omnibus-vi-easing-cosmetics-and-chemical-rules</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T09:46:32.346Z</news:publication_date>
      <news:title>EU Signs Off on Omnibus VI, Easing Cosmetics and Chemical Rules</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/beauty-editor-s-nose-spot-turned-out-to-be-morpheaform-bcc</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T08:55:05.160Z</news:publication_date>
      <news:title>Beauty Editor&apos;s Nose Spot Turned Out to Be Morpheaform BCC</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/psoriasis-roundtable-60-7-scalp-response-and-coverage-barriers</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T02:53:48.910Z</news:publication_date>
      <news:title>Psoriasis roundtable: 60.7% scalp response and coverage barriers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dupilumab-linked-to-height-percentile-gains-in-pediatric-ad</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T01:28:38.215Z</news:publication_date>
      <news:title>Dupilumab linked to height-percentile gains in pediatric AD</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/eu-clears-700-mg-every-6-week-cemiplimab-dosing-across-all-six-indications</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T01:28:38.215Z</news:publication_date>
      <news:title>EU Clears 700-mg Every-6-Week Cemiplimab Dosing Across All Six Indications</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/np-private-practice-medicare-pay-120-day-credentialing</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T01:28:38.215Z</news:publication_date>
      <news:title>NP Private Practice in 2026: 85% Medicare Pay, 120-Day Credentialing</news:title>
    </news:news>
  </url>
</urlset>
